1,338 results on '"Kozikowski, Alan P."'
Search Results
2. Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors
3. Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism
4. The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes
5. Novel HDAC Inhibitors with Radiosensitizing Properties
6. Therapeutic Effects of PKC Activators in Alzheimer's Disease Transgenic Mice
7. Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists
8. Supplementary Data from Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer
9. Data from Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer
10. Supplementary Figure 2 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
11. Supplementary Table from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
12. Supplementary Figure 3 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
13. Data from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
14. Supplementary Figure Legends from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
15. Supplementary Figure 4 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
16. Supplementary Figure 1 from GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
17. Supplementary Materials, Figures 1 - 2, Table 1 from The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors
18. Data from The RAD51-Stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors
19. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease
20. Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6).
21. Pharmacokinetics and brain penetration of LF-3-88, (2-[5-[5-(2(S)-azetidinylmethoxyl)-3-pyridyl]-3-isoxazolyl]ethanol), a selective α4β2-nAChR partial agonist and promising antidepressant
22. Characterization of C-10 Substituted Analogues of Huperzine A as Inhibitors of Cholinesterases
23. HDAC6 Is a Target for Protection and Regeneration following Injury in the Nervous System
24. The Combination of Huperzine A and Imidazenil Is an Effective Strategy to Prevent Diisopropyl Fluorophosphate Toxicity in Mice
25. A microenvironment-mediated c-Myc/ miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
26. Targeting the Number Two Infectious Disease Killer--Tuberculosis
27. Clinical and Preclinical Studies with Huperzine
28. Natural product leads for drug discovery: Isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3- a]carbazole based ligands as antibacterial agents
29. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
30. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
31. Dysregulation of glutamate carboxypeptidase II in psychiatric disease
32. Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3β inhibitors
33. Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot–Marie–Tooth Type 2A Mouse Model
34. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
35. Regional Anesthesia and Pain: Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain
36. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. Possible new GSK-3[beta] therapies for bipolar disorders
37. Role of the increased noradrenergic neurotransmission in drug self-administration
38. Neuroprotective effects of the agonist of metabotropic glutamate receptors ABHxD-I in two animal models of cerebral ischaemia
39. RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
40. A tandem Michael addition ring-closure route to the metabotropic receptor ligand alpha-(hydroxymethyl)glutamic acid and its gamma-alkylated derivatives
41. Studies in polyphenol chemistry and bioactivity. Stereocontrolled synthesis of epicatechin-4alpha,8-epicatechin, an unnatural isomer of the B-type procyanidins,3
42. On the path from chemistry to neuroscience: Early explorations in chemical medicine under the mentorship of Dr. Erminio Costa, a neuroscientist with a big brain and a bigger heart
43. Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models
44. HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice
45. Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus
46. Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands
47. Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
48. Studies in polyphenol chemistry and bioactivity. establishment of interflavan linkage regio- and stereochemistry by oxidative degradation of an O-alkylated derivative of procyanidin B(sub)2 to (R)-(--)-2,4-diphenylbutyric acid
49. A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
50. Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.